Carlo Tanzi | IR |
Eric Shaff | President and CEO |
David Arkowitz | CFO |
Matthew Henn | Chief Scientific Officer |
Lisa von Moltke | Chief Medical Officer |
Terri Young | Chief Commercial and Strategy Officer |
Mark Breidenbach | Oppenheimer |
John Newman | Canaccord Genuity |
Chris Howerton | Jefferies |
Ted Tenthoff | Piper Sandler |
Peyton Bohnsack | Cowen |
Chris Shibutani | Goldman Sachs |
Keay Nakae | Chardan |
Good morning ladies and gentlemen, and welcome to the Seres Therapeutics Q2 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Dr. Carlo Tanzi of Investor Relations.
Thank you and good morning.